19 June 2013
Keywords: further, eu, approval, s-p, hcv, drug, combo
Article | 26 November 2007
US drug major Schering-Plough says that the European Commission has approved 48-week standard-dose Pegintron (peginterferon alfa-2b,
1.5mcg/kg once-weekly) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 November 2007
3 December 2007
18 June 2013
© 2013 thepharmaletter.com